714 assets in Colorectal Cancer

Therapeutic assets addressing Colorectal Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Enfortumab Vedotin (Fully Human Monoclonal Antibody Conjugated To A Cytotoxic Agent Monomethyl Auristatin E (Mmae) Targeting Nectin-4) Colorectal Cancer	H. Lee Moffitt Cancer Center and Research Institute	P2	CCC (48)
FAPI74 Colorectal Cancer	SOFIE	P2	CCC (48)
Gamma1 Heavy Chain Humanized (1-450) [Vh (Homo Sapiens Ighv4-3101 (89.9%) -(Ighd) -Ighj401 (92.9%), Cdr-Imgt [9.7.13] (26-34.52-58.97-109)) (1-120) -Homo Sapiens Ighg101 (100%), G1M17,1 Ch1 K120, D12, L14 (Ch1 K120 (217) (121-218), Hinge 1-15 (219-233), Ch2 (234-343), Ch3 D12 (359), L14 (361) (344-448), Chs (449-450)) (121-450)], (223-214')-Disulfide With Kappa Light Chain Humanized (1'-214') [V-Kappa (Homo Sapiens Igkv1-1201 (85.3%)-Igkj201 (100%), Cdr-Imgt [6.3.9] (27-32.50-52.89-97)) (1'-107') -Homo Sapiens Igkc01 (100%), Km3 A45.1 (153), V101 (191) (108'-214')]; Dimer (229-229'':232-232'')-Bisdisulfide, Produced In Chinese Hamster Ovary (Cho) Cells, Derived From The Cell Line Cho-K1,Glycoform Alfa Colorectal Cancer	Cancer Research UK	P1/2	CCC (48)
GEH300079 (68Ga) Colorectal Cancer	GE Healthcare	P2/3	CCC (48)
Grt-C903 Colorectal Cancer	National Cancer Institute (NCI)	P1/2	CCC (48)
Grt-R904 Colorectal Cancer	National Cancer Institute (NCI)	P1/2	CCC (48)
hlx208 Colorectal Cancer	Shanghai Henlius Biotech	P2	CCC (48)
hr070803 Colorectal Cancer	Jiangsu HengRui Medicine Co., Ltd.	P2/3	CCC (48)
Jab-21822 Colorectal Cancer	Jian Li	P1/2	CCC (48)
js212 Colorectal Cancer	Shanghai Junshi Bioscience Co., Ltd.	P2	CCC (48)
Larotrectinib Colorectal Cancer	Oslo University Hospital	P2	CCC (48)
Ligufalimab Colorectal Cancer	Akeso	P2	CCC (48)
Max-40279-01 Colorectal Cancer	Maxinovel Pty., Ltd.	P2	CCC (48)
Mycobacterium Obuense Colorectal Cancer	AIO-Studien-gGmbH	P2	CCC (48)
Ompenaclid Colorectal Cancer	Inspirna, Inc.	P2	CCC (48)
Osimertinib Colorectal Cancer	Genentech, Inc.	P1/2	CCC (48)
Petrozumab Colorectal Cancer	Oslo University Hospital	P2	CCC (48)
Pidnarulex Colorectal Cancer	National Cancer Institute (NCI)	P1/2	CCC (48)
Prolgolimab Colorectal Cancer	Blokhin's Russian Cancer Research Center	P2	CCC (48)
rbs2418 Colorectal Cancer	Riboscience, LLC.	P2	CCC (48)
Retifanlimab Colorectal Cancer	National Cancer Institute (NCI)	P1/2	CCC (48)
Rmc-6236 Colorectal Cancer	Revolution Medicines, Inc.	P1/2	CCC (48)
rxc004 Colorectal Cancer	Redx Pharma Ltd	P2	CCC (48)
sc0191 Colorectal Cancer	Tianshu Liu	P2	CCC (48)
Sirexatamab Colorectal Cancer	Leap Therapeutics, Inc.	P2	CCC (48)
Sotevtamab Colorectal Cancer	Alethia Biotherapeutics	P2	CCC (48)
Ssgj-707 Colorectal Cancer	Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.	P2	CCC (48)
Stc-1010 Colorectal Cancer	Brenus Pharma	P1/2	CCC (48)
Tinodasertib Colorectal Cancer	AUM Biosciences Pte Ltd	P2	CCC (48)
Tuvusertib Colorectal Cancer	National Cancer Institute (NCI)	P1/2	CCC (48)
Valproic Acid Colorectal Cancer	Australasian Gastro-Intestinal Trials Group	P2	CCC (48)
vg2025 Colorectal Cancer	Akeso	P1/2	CCC (48)
Vorbipiprant Colorectal Cancer	Rottapharm Biotech	P1/2	CCC (48)
Young Til Colorectal Cancer	National Cancer Institute (NCI)	P2	CCC (48)
5-ala Colorectal Cancer	Roswell Park Cancer Institute	P1/2	CC (47)
Abt-301 Colorectal Cancer	Anbogen Therapeutics, Inc.	P1/2	CC (47)
Autologous Immune Cells Colorectal Cancer	Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.	P1/2	CC (47)
Devimistat Colorectal Cancer	Northwestern University	P2	CC (47)
Dual-Target Antigen-Selected Car-Nk Colorectal Cancer	Essen Biotech	P1/2	CC (47)
Eb-Select Single-Target Car-Nk Cells Colorectal Cancer	Essen Biotech	P1/2	CC (47)
lpm6690176 Colorectal Cancer	Luye Pharma Group Ltd.	P1/2	CC (47)
Midazolam Colorectal Cancer	Alterome Therapeutics, Inc.	P1	CC (47)
Modotuximab Colorectal Cancer	Institut de Recherches Internationales Servier	P3	CC (47)
sbt6050 Colorectal Cancer	Silverback Therapeutics	P1/2	CC (47)
Tegavivint Colorectal Cancer	HonorHealth Research Institute	P1/2	CC (47)
Agen1423 Colorectal Cancer	Weill Medical College of Cornell University	P2	CC (46)
Aguix Colorectal Cancer	Brigham and Women's Hospital	P2	CC (46)
Aipalolitovorelizumab Colorectal Cancer	Yanqiao Zhang	P2	CC (46)
All Trans Retinoic Acid Colorectal Cancer	University of Texas Southwestern Medical Center	P2	CC (46)
Amb-05X Colorectal Cancer	M.D. Anderson Cancer Center	P2	CC (46)

Showing 251 to 300 of 714 assets

PreviousPage 6 of 15Next